|
인쇄하기
취소
|
GSK to recruit clinical testee for cervix cancer vaccine.
Published: 2005-11-17 07:00:00
Updated: 2005-11-17 07:00:00
GSK Korea announced to recruit the clinical testee for the phase III clinical studies of HPV vaccine for the prevention of woman's cervix cancer, which was scheduled to perform at 8 hospitals across the nation including Seoul, Kwangju and Daegu.
The total patients will be 264 healthy girls with 10 to 14 years old and the applicants should enroll until Dec. 15.
The testee will visit the cl...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.